SecBot SecBot
144 ·Filed Oct 27, 2026

NTRA

Natera, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed5d 6h ago SEC0002010135-26-000022
Actionable Insight • Neutral

The filings are routine RSU-vesting sales by multiple officers and directors, consistent with a pattern of regular insider selling. The amounts are small relative to market cap and prior sale volumes. Monitor for any acceleration in selling volume or unexpected departures, but no immediate concern is warranted.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled: T+1d ⚠ clustered
NTRA ▲ +2.73% at T+1d
NEUTRAL call +2.73% · α vs SPY +3.11% · entry $424.42 → $436.00
Next anchor: T+5d tomorrow
Entry = T+0 close
Oct 27, 2026
via day close
T+1d
+2.73%
call +2.73% · α +3.11%
$436.00
settled 5d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 22d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Five Natera insiders (CEO John Fesko, COO Solomon Moshkevich, CLO Daniel Rabinowitz, Director Matthew Rabinowitz, and Director Jonathan Sheena) filed Form 144 notices on October 27, 2026, signaling intent to sell shares acquired from RSU vesting. The proposed sales total approximately 4,625 shares worth about $1.87 million combined, with the largest single proposed sale being Director Matthew Rabinowitz's 1,697 shares (~$687K). These filings follow a pattern of recent insider selling and come as the stock trades near a $58.2B market cap with strong analyst support.

Key Facts

  • Five Form 144 filings filed on October 27, 2026 by Natera insiders: CEO John Fesko (771 shares, ~$312K), COO Solomon Moshkevich (997 shares, ~$404K), CLO Daniel Rabinowitz (873 shares, ~$353K), Director Matthew Rabinowitz (1,697 shares, ~$687K), and Director Jonathan Sheena (287 shares, ~$116K).
  • All proposed sales are of shares acquired from RSU vesting on October 26, 2026, with the original RSU grant dated January 26, 2024.
  • The total proposed sale value across all five filings is approximately $1.87 million.
  • All sales are planned to be executed through ETrade Corporation on the Nasdaq exchange.
  • Recent insider activity in the 30 days prior shows 10 sells totaling $1.5 million, and the filings reveal substantial prior sales by these same insiders over the past three months (e.g., Matthew Rabinowitz sold 200,000 shares in September-October 2026 for ~$70.6M; Solomon Moshkevich sold over 25,000 shares in the same period for ~$8.7M).
  • Market cap is $58.2B with 30 analyst ratings (12 Strong Buy, 15 Buy, 3 Hold).

Financial Impact

Proposed sales total ~$1.87M, representing less than 0.01% of Natera's $58.2B market cap. The filings are for routine RSU-vesting sales, not large directional bets.

dilutioninsider ownership

Risk Factors

  • Concentrated insider selling by multiple top executives on the same day could signal a lack of confidence, though the amounts here are small and tied to RSU vesting.
  • The filings are only intent to sell; actual sales may not occur.
  • No earnings or guidance data was provided in the filing context to assess fundamental performance.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
90% bullish (30 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 15 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (NTRA), Batch item 10002010135-26-000022
Document: 0002010135-26-000022-index.html0002010019-26-000032
Document: 0002010135-26-000022.txt0001857843-26-000027
144 Filing (NTRA), Batch item 40002010019-26-000032
Document: 0002010019-26-000032-index.html0001646649-26-000037
Document: 0002010019-26-000032.txt0002010135-26-000022
144 Filing (NTRA), Batch item 70001857843-26-000027
Document: 0001857843-26-000027-index.html0002010135-26-000022
Document: 0001857843-26-000027.txt0002010135-26-000022
144 Filing (NTRA), Batch item 100001646382-26-000025
Document: 0001646382-26-000025-index.html0002010135-26-000022
Document: 0001646382-26-000025.txt0002010135-26-000022
144 Filing (NTRA), Batch item 130001646649-26-000037
Document: 0001646649-26-000037-index.html0002010135-26-000022
Document: 0001646649-26-000037.txt0002010135-26-000022
51 reports for NTRA
Performance horizon
67% Hit rate @ T+1 6 of 9 directional calls Went positive at some point 6 of 9 best @ T+5▲ +6.55%Oct 2, 2026
Filters
Rows
Reports for NTRA, sortable and filterable
TypeNow
Oct 30, 2026
2d ago
Insider Cluster
NEUTRAL ★ 2/10
$422.53awaiting T+1awaiting T+1$414.30 (−1.95%)
Oct 30, 2026
2d ago
144
NEUTRAL ★ 3/10
$422.53awaiting T+1awaiting T+1$414.30 (−1.95%)
Oct 29, 2026
3d ago
Insider Cluster
NEUTRAL ★ 3/10
$422.53awaiting T+1awaiting T+1$414.30 (−1.95%)
Oct 28, 2026
4d ago
144
NEUTRAL ★ 2/10
$436.00 $414.30▼ −4.98%▼ −3.20%$414.30 (−4.98%)
Oct 28, 2026
4d ago
144
NEUTRAL ★ 3/10
$436.00 $414.30▼ −4.98%▼ −3.20%$414.30 (−4.98%)
Oct 28, 2026
4d ago
144
NEUTRAL ★ 2/10
$424.42 $436.00▲ +2.73%▲ +3.11%$414.30 (−2.38%)
Oct 28, 2026
5d ago
Court Ruling
BULLISH ★ 4/10
$424.42 $436.00▲ +2.73%▲ +3.11%$414.30 (−2.38%)
Oct 27, 2026
5d ago
Institutional Cluster
MIXED ★ 3/10
$424.42 $436.00▲ +2.73%▲ +3.11%$414.30 (−2.38%)
Oct 27, 2026
5d ago
144
NEUTRAL ★ 3/10
$424.42 $436.00▲ +2.73%▲ +3.11%$414.30 (−2.38%)
Oct 27, 2026
5d ago
144
NEUTRAL ★ 2/10
$424.42 $436.00▲ +2.73%▲ +3.11%$414.30 (−2.38%)
Showing 10 of 51

US Market Status

Market Closed · Opens Tue (11h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026